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     INTRODUCTION 
  Scrub typhus, caused by   Orientia tsutsugamushi  , and murine 
typhus, caused by   Rickettsia typhi  , are important acute febrile 
illnesses in the Asia–Pacific region.  1–  4   Clinical diagnosis of 
typhus is difficult because signs and symptoms are similar 
to those of many other febrile diseases such as typhoid, lep-
tospirosis, and dengue virus infection. Laboratory diagnosis of 
scrub typhus and murine typhus infection has relied on the 
detection of antibodies to   O. tsutsugamushi   and   R. typhi ,  and 
the gold standard assay is the indirect immunofluorescent 
antibody (IFA) assay.  5   Development of rapid diagnostic tests 
using immunochromatographic test (ICT) or immunoblot test 
(IBT) technologies has provided a mechanism for point-of-
care serologic testing. To date, there is limited information on 
the utility of rapid tests for the diagnosis of acute scrub and 
murine typhus, and published information has concentrated 
on whole antibody rather than IgM-specific tests.  6  
  We assessed the diagnostic capacity of a commercially 
available rapid ICT for detection of IgM against   O. tsutsuga-
mushi   and an IBT for detection of IgM against   R. typhi   to aid 
the diagnosis of acute scrub and murine typhus infection in 
patients in the tropical and disease-endemic environment of 
the Lao People’s Democratic Republic (Laos). 
   MATERIALS AND  METHODS 
  Patient  samples.     The study was conducted at Mahosot 
Hospital in Vientiane, Laos during March 2003–May 2007. 
Ethical clearance was granted by the Ethical Review Committee 
of the Faculty of Medical Sciences, National University of 
Laos, Vientiane, Laos, and by the Oxford University Tropical 
Ethics Research Committee, United Kingdom. After informed 
written consent was obtained, consecutive inpatients of any 
age were recruited if the responsible physician suspected 
typhus, characterized by a minimum of fever, headache, and/
or myalgia. Venous blood samples were collected on the day 
of admission and during convalescence at or after discharge 
from the hospital. Serum was divided for immediate use and 
for storage at –80°C. 
   Indirect  immunofluorescent  antibody  assay.    IgM  against 
scrub typhus ( O. tsutsugamushi  pooled Karp, Kato, and Gilliam 
antigens) and murine typhus (  R. typhi   Wilmington  strain 
antigen) IgM was detected by using an IFA assay.  5   Slides for 
the IFA assay were obtained from the Australian Rickettsial 
Reference Laboratory (Geelong, Victoria, Australia). Briefly, 
patient serum samples was serially diluted two-fold from 1:100 
to 1:25,600 in phosphate-buffered saline (PBS) containing 2% 
(w/v) skim milk powder, incubated in a humidified atmosphere 
for 30 minutes at 37°C, and washed three times in PBS. Anti-
human IgM fluorescein isothiocyanate conjugate (Jackson 
ImmunoResearch Laboratories, West Grove, PA) diluted in 
PBS–skim milk powder diluent containing 0.00125% (w/v) 
Evans Blue counterstain was applied to all wells, and wells were 
incubated in a humidified atmosphere for 30 minutes at 37°C. 
Slides were examined by epifluorescence microscopy (BX50; 
Olympus, Tokyo, Japan) by two observers at a magnification of 
400×. The binding endpoint titer was determined as the highest 
titer that showed fluorescence. 
   Scrub  typhus  immunochromatographic  test.    The  scrub  typhus 
ICT (Panbio, Sinnamon Park, Queensland, Australia) (ST 
ICT) was performed on admission-phase specimens according 
to the manufacturer’s instructions. Briefly, 5 μL of serum was 
applied to the reagent pad of the ICT strip and two drops of 
buffer was added. Results were read visually 10 minutes later. 
Results were recorded as positive, equivocal, or negative for 
the IgM against   O. tsutsugamushi   and control lines. Because 
the tests were performed in a routine hospital laboratory with 
staff rotation, these tests were read individually by trained 
operators under the direction of the study supervisor at 
Mahosot Hospital. 
   Murine  typhus  Dip-S-Ticks  test.     The Murine typhus Dip-S-
Ticks IBT (Panbio) (MT IBT) was performed on admission 
specimens according to the manufacturer’s instructions with the 
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modification that the manufacturer provided goat anti-human 
IgG and alkaline phosphatase–conjugated goat anti-human 
IgM to make the assay specific for detection of IgM. Samples 
were assessed by trained staff in a routine hospital laboratory, 
as described above. Using the interpretation provided by 
the manufacturer, the presence of ≤ 2 dots was considered 
not seroreactive with IgM against   R. typhi   and thus negative. 
Samples that resulted in 3 or 4 dots were considered 
seroreactive with IgM against   R. typhi . 
   Data  analysis.     Diagnostic accuracy was calculated using ST 
ICT and MT IBT results compared with the gold standard 
reference IFA assay results for each patient sample. The gold 
standard reference IFA assay result used in this study was 
that an admission-phase sample IgM IFA assay titer ≥ 1:400  7  
or a four-fold increase between paired admission-phase and 
convalescent-phase serum samples was diagnostic for scrub 
typhus. In this study, we have also used a combination of these 
diagnostic criteria (i.e., combined ≥ 4-fold increase in titer or 
admission-phase titer ≥ 1:400) as a reference comparator. We 
also used these criteria for serologic diagnosis of murine typhus 
infection because there are no evidence-based guidelines for 
IFA assay cut-off values for this disease. Equivocal ST ICT 
and MT IBT results were considered negative for the final 
analysis. A 2 × 2 table was constructed where the gold standard 
result was cross-tabulated with the ST ICT and MT IBT 
results to define true-positive, false-positive, false-negative, 
and true-negative values. Standard diagnostic accuracy indices 
of sensitivity, specificity with exact 95% confidence intervals 
(CIs) and interquartile ranges (IQRs) of days of fever were 
calculated by using Stata/SE 8.0 (Stata Corp., College Station, 
TX). Significant differences (  P   < 0.05) between rapid test 
positivity rates and days of fever and IgM IFA assay titer and 
assay cross-reactivity using different diagnostic criteria were 
calculated by using Pearson’s chi-square test. 
   Assessment  of  diagnostic  utility.     To examine the true 
diagnostic utility of the rapid tests in a clinical setting, four 
questions were posed.  
    1) In a patient with suspected acute typhus infection, how 
accurate were the ST ICT and MT IBT for diagnosis of scrub 
and murine typhus, respectively, in absolute terms when com-
pared with the above mentioned established IFA diagnostic 
criteria?  7   This comparison rates the ability of the test to make 
the correct diagnosis on the admission-phase sample com-
pared with the final, retrospective, gold standard diagnosis 
made using admission-phase and convalescence-phase serum 
samples. It is a test of the accuracy of the rapid tests because 
there may not be sufficient IgM present on admission in a 
patient ultimately diagnosed as having the disease on the basis 
of increasing titers with a paired convalescent-phase sample. 
Thus, this tests the premise on which the rapid diagnostic test 
is based and the ability of the test to correctly detect the pres-
ence of IgM.   
    2)     What is the relative accuracy of the admission ST ICT 
and MT IBT for the detection of IgM compared with the gold 
standard   O. tsutsugamushi   and   R. typhi   admission-phase IgM 
IFA assays?   
    3)     What is the effect of cross-reactivity between antibodies 
to   O. tsutsugamushi   and   R. typhi   on the diagnostic utility of ST 
ICT and MT IBT compared with gold standard IFA assays for 
antibodies against   O. tsutsugamushi   and   R. typhi ?  
    4)     What is the effect of sample timing, in relation to the 
duration of illness, on the ST ICT and MT IBT positivity rates 
for IgM against   O. tsutsugamushi   and   R. typhi   IFA assay-pos-
itive  patients?    
    RESULTS 
  Patient  samples.    Admission-phase  and  convalescent-phase 
serum samples (n = 2,060) from 1,030 patients (median age = 28 
years, IQR = 20–42 years) were evaluated by   O. tsutsugamushi  
and  R. typhi  IgM IFA reference serologic analysis to determine 
scrub and murine typhus antibody status of the patients. 
A total of 8.3% (86 of 1,030) of the patients were children 
(age < 15 years). All patients were assessed by using the ST 
ICT and the MT IBT. Median number of days of fever at the 
time of collection of the admission-phase sample was 6 (IQR = 
5–10 days), and median interval between obtaining admission-
phase and convalescent-phase samples was 7 days (IQR = 
5–10 days). 
   Reference  assay.     For scrub typhus IFA reference testing, 
101 (9.8%) of 1,030 patients had a ≥ 4-fold increase in titer 
between paired specimens in   O. tsutsugamushi   IFAs, and 376 
(36.1%) of 1,030 patients had admission-phase IgM titers 
≥ 1:400. Four hundred twenty-six (41.4%) of 1,030 patients 
had admission-phase IgM titers ≥ 1:400 or a ≥ 4-fold increase 
in titer between paired specimens (  Table 1  ). 
      For murine typhus IFA reference testing, 183 (17.8%) of 1,030 
patients had a ≥ 4-fold increase in titer between paired speci-
mens in the  R. typhi  IFAs, and 339 (32.9%) of 1,030 patients had 
admission-phase IgM titers ≥ 1:400. Four hundred nine (39.7%) 
of 1,030 patients had admission-phase IgM titers ≥ 1:400 or a 
≥ 4-fold increase in titer between paired specimens (  Table 1  ). 
   Diagnostic  accuracy  questions.     
    1)     In   a patient with suspected acute typhus infection, how 
accurate were the ST ICT and MT IBT in diagnosis 
of scrub and murine typhus, respectively, in absolute 
terms, when compared with previously established 
diagnostic criteria for scrub typhus?       
 Table 1 
    Sensitivity and specificity for the scrub typhus ICT and murine typhus IBT for detection of IgM compared with the gold standard IgM antibody 
IFA  assay *   
    *     ICT = immunochromatographic test; IBT = immunoblot test; IFA = indirect immunofluorescent antibody; CI = confidence interval.  
Admission sample gold standard 
IFA diagnostic criteria
Scrub typhus IgM ICT Murine typhus IgM IBT
No. (n = 1,030) Sensitivity, % (95% CI) Specificity, % (95% CI) No. (n = 1,030) Sensitivity, % (95% CI) Specificity, % (95% CI)
Four-fold increase in IgM 
(paired samples) 101 23.8 (15.9–33.3) 86.2 (84.1–88.6) 183 61.2 (53.7–68.3) 86.5 (84.1–88.8)
IgM ≥ 1:400 on admission 376 39.1 (34.1–44.2) 99.5 (98.7–99.9) 339 54.6 (49.1–60.0) 94.1 (92.0–95.7)
Four-fold increase in IgM or 
IgM ≥ 1:400 on admission 426 34.7 (30.2–39.5) 99.7 (98.8–100) 409 48.4 (43.5–53.4) 95.5 (93.5–97.0)367 ACCURACY OF RAPID TESTS FOR SCRUB AND MURINE TYPHUS
  For the ST ICT, when we used the stringent ≥ 4-fold increase 
in IFA titer between paired serum samples as the diagnostic 
criterion, sensitivity of the ST ICT for admission-phase samples 
was 23.8% (24 of 101; 95% CI = 15.9–33.3%). For patients with 
an IgM IFA titer ≥ 1:400, sensitivity was 39.1% (147 of 376; 95% 
CI = 34.1–44.2%). Specificities were 86.2% (126 of 929; 95% 
CI = 84.1–88.6%) and 99.5% (3 of 654; 95% CI = 98.7–99.9%), 
respectively. For samples with a ≥ 4-fold increased IFA titer 
between paired serum samples or IgM IFA titer ≥ 1:400, sensi-
tivity was 34.7% (148 of 426; 95% CI = 30.2–39.5%) and speci-
ficity was 99.7% (2 of 604; 95% CI = 98.8–100%) (  Table 1  ). 
  For the MT IBT, when we used the stringent ≥ 4-fold 
increase in IFA titer between paired serum samples as the 
diagnostic criterion, sensitivity of the MT IBT for admission-
phase samples was 61.2% (112 of 183; 95% CI = 53.7–68.3%). 
For patients with an IgM IFA titer ≥ 1:400, sensitivity was 
54.6% (185 of 339, 95% CI = 49.1–60.0%). Specificities were 
moderately high at 86.5% (114 of 847; 95% CI = 84.1–88.8%) 
and 94.1% (41 of 691; 95% CI = 92.0–95.7%), respectively. For 
samples with ≥ 4-fold rising IFA titer between paired serum 
samples or IgM IFA titer ≥ 1:400, sensitivity was 48.4% (198 
of 409; 95% CI = 43.5–53.4%) and specificity was 95.5% (28 of 
621; 95% CI = 93.5–97.0%) (  Table 1  ). 
    2)     What is the relative accuracy of the admission ST ICT 
and MT IBT for the detection of IgM compared with the gold 
standard   O. tsutsugamushi   and   R. typhi   admission-phase IgM 
IFA  assays?    
  There was a significant association between ST ICT and MT 
IBT positivity rates and increasing IFA IgM titers (ST ICT 
and MT IBT Pearson’s χ  2   = 697.2 and 445.4, respectively; both 
  P   < 0.00005) (  Figure 1  ). The MT IBT was more sensitive for 
detecting antibodies to  R. typhi  than the ST ICT was for detect-
ing antibodies to   O. tsutsgamushi  , and the lowest IFA titers to 
reach the 50% sensitivity threshold were 1:1,600 and 1:3,200, 
respectively (  Figure 1  ). Importantly, the diagnostically infor-
mative > 80% sensitivity threshold was reached at IFA titers of 
1:12,800 for the ST ICT and 1:3,200 for the MT IBT (  Figure 1  ). 
This finding was also clearly demonstrated by increased accu-
racy when ST ICT and MT IBT results for paired samples with 
admission IgM titers ≥ 1:3,200 were compared. In the case of 
the ST ICT (n = 147), sensitivity for antibody to   O. tsutsuga-
mushi   was 83.0% (95% CI = 75.9–88.7%) and the specificity 
was 96.8% (95% CI = 95.4–97.9%). For the MT IBT (n = 74) 
sensitivity for antibody to   R. typhi   was 94.6% (95% CI = 86.7–
98.5%) and specificity was 83.7% (81.2–86.0%). 
    3)     What is the effect of cross-reactivity between antibodies 
to   O. tsutsugamushi   and   R. typhi   on the diagnostic utility of ST 
ICT and MT IBT compared with gold standard IFA assays for 
antibodies against   O. tsutsugamushi   and   R. typhi ?     
    We investigated the utility of the ST ICT and MT IBT to 
detect heterologous antibodies for detection of both typhus 
diseases. Cross-reactivity in the MT IBT for detection of anti-
bodies to scrub typhus ranged from 16.7% to 17.8% depend-
ing on the diagnostic criteria used (  Table 2  ). When we used the 
stringent four-fold increasing diagnostic criteria, of 101 sam-
ples indicating scrub typhus, 17.8% (95% CI = 11.6–26.4%) 
showed a positive reaction in the MT IBT. The ST ICT was 
marginally more specific than the MT IBT; murine typhus 
antibody cross-reactivity ranging from 9.8% to 15.9% depend-
ing on the diagnostic criteria used (  Table 2  ). When we used the 
stringent four-fold increasing diagnostic criteria, of 183 sam-
ples indicating murine typhus, 9.8% (95% CI = 6.3–15.1%) 
showed a positive reaction in the ST ICT. There was no sig-
nificant difference in cross-reactivity between the two assays 
when the diagnostic criteria were used. 
    4)     What is the effect of sample timing, in relation to the 
duration of illness, on the ST ICT and MT IBT positivity rates 
for IgM against   O. tsutsugamushi   and   R. typhi   IFA assay-
positive  patients?    
            Rapid test positivity rates for the three reference diagnostic 
criteria were largely constant with increasing days of illness 
for both rapid tests until day 10 or 12 of fever when there was a 
marked increase in positivity (  Figure 2  ). The ST ICT positivity 
rates remained at < 50% from day 1 to day 10 of illness when there 
was an increase to approximately 60% positivity (  Figure 2A  ). 
The MT IBT maintained a positivity range of 40–60% from 
day 1 to day 12, followed by an increase to approximately 
between 60% and 80% positivity (  Figure 2B  ). 
     DISCUSSION 
 This study examined the accuracy of the Panbio scrub typhus 
ICT and the murine typhus IBT in IgM formats for diagnosis 
of scrub and murine typhus in a prospectively recruited series 
of patients with typhus-like illness in an area where scrub and 
murine typhus are common.  2  
  The ST ICT and MT IBT had low sensitivity for accurate 
diagnosis of typhus for admission-phase specimens, which 
suggested that these rapid assays have limited usefulness for 
diagnosis of typhus-like illness in this disease-endemic setting. 
Comparison with reference IFA techniques demonstrated 
that much higher antibody titers than patients would normally 
have on admission (range = 1:3,200–12,800) were required 
to generate positive results in the rapid assays. Sensitivity of 
these assays may be improved by increasing the amount of 
antigen on the test strips. 
  The time when the sample was obtained was an important 
factor in accuracy of the rapid tests. The ST ICT did not show 
acceptable levels of sensitivity until well after the median day 
of presentation in this study (seven days), which was reflected 
in poor overall sensitivity results. This effect was less pro-
nounced for the MT IBT. 
 Figure 1.        Proportional positivity for the scrub typhus immu-
nochromatograpic test and the murine typhus immunoblot test for 
detection of IgM compared with the gold standard IgM indirect immu-
nofluorescent  antibody  assay.    368 BLACKSELL AND OTHERS
  Given that the current recommendations for treatment 
of scrub and murine typhus are similar, oral doxycycline for 
seven days,  8   a test that would be reactive for scrub and murine 
typhus would be potentially useful. In this study, we investi-
gated the applications of the MT IBT for this purpose because 
it demonstrated cross-reactivity for patients with scrub typhus 
at a level that approached that of the ST ICT. However, the 
sensitivity was insufficient for application with admission-
phase samples. 
  For the scrub typhus ICT, accuracy estimates were lower 
than those in previous studies with the same product; sensi-
tivities ranged from 74% to 96% and specificities ranged from 
86% to 99%.  9,  10   Previous studies have evaluated the murine 
typhus IBT for detection of total antibodies rather than only 
IgM.  6,  11,  12   Sensitivity and specificity ranged from 51.4% to 
100%, respectively, for prospectively collected samples  12   to 
91.4% and 87.7%, respectively, for stored serum samples.  11  
Results in this study are similar to those of previous studies 
although accuracies were generally lower. 
  In this study, we used three diagnostic reference standards; 
the four-fold increasing antibody titer in paired samples, an 
admission IFA IgM titer ≥ 1:400,  7   and a combination of both cri-
teria. The application of these different diagnostic criteria dem-
onstrated clear differences in sensitivity results. The IFA IgM 
titer ≥ 1:400 diagnostic criterion showed lower sensitivity and 
positivity for the MT IBT than the supposedly more stringent 
four-fold increasing antibody titer in paired samples. A clear dis-
crepancy was also noted between the two reference standards 
when ST ICT positivity was compared with increasing time 
of sample collection; this was less of an the issue with the MT 
IBT. Specificity results were much lower for both tests when the 
four-fold increasing antibody titer in paired samples was used as 
the diagnostic criterion. This result reinforces the problem with 
application of an appropriate IFA assay diagnostic criteria and/
or reference standard for rickettsial diseases  13   which is exacer-
bated by residual IgM against scrub typhus or murine typhus 
from previous infections, which may persist for many months.  7   
  An additional issue affecting sensitivity is that it is likely 
that   O. tsutsugamushi   in Laos are antigenically diverse,  14   and 
there may be strains undetected by antibodies against the 
Karp, Kato, and Gilliam strains. Similar issues may affect 
  R. typhi   diagnosis, but there are few data to make this judgment. 
  This study has demonstrated that in a low-resource, typhus-
endemic setting, the Panbio scrub typhus ICT and murine 
 Figure  2 .      A  , Effect of sample collection timing (days of illness) on positivity of the immunochromatographic test for detection of IgM against 
scrub typhus compared with reference assay positivity criteria of a scrub typhus IgM titer ≥ 1:400 in the acute-phase sample, a ≥ 4-fold increase in 
IgM in paired sample collections, and a combined ≥ 4-fold increase in IgM and a ≥ 1:400 IgM titer result.   B  , Effect of sample collection timing (days 
of illness) on positivity of the immunoblot test for the detection of IgM against murine typhus compared with reference assay positivity criteria of 
murine typhus IgM titer ≥ 1:400 in the acute-phase sample, a ≥ 4-fold increase in IgM in paired sample collections, and a combined ≥ 4-fold increase 
in IgM and ≥ 1:400 IgM titer result.       
 Table 2 
    Proportional heterologous reactivity of scrub typhus ICT and murine typhus IBT for detection of IgM compared with differing gold standard IgM 
IFA assay diagnostic criteria  *     
    *     ICT = immunochromatographic test; IBT = immunoblot test; IFA = indirect immunofluorescent antibody; CI = confidence interval.  
Diagnostic criteria
% Heterologous cross reaction (95% CI)
χ  2   ( P ) No.
Scrub typhus–positive samples with a positive 
result in murine typhus IgM IBT No.
Murine typhus–positive samples with a positive 
result in scrub typhus IgM ICT
Four-fold increase in IgM 101 17.8 (11.6–26.4) 183 9.8 (6.3–15.1) 2.85 (0.09)
IgM ≥ 1:400 admission 376 17.6 (14.0–21.7) 339 15.0 (11.6–19.2) 0.66 (0.80)
Four-fold increase in IgM or IgM ≥ 
1:400 on admission 426 16.7 (13.4–20.5) 409 15.9 (12.7–19.8) 0.59 (0.44)369 ACCURACY OF RAPID TESTS FOR SCRUB AND MURINE TYPHUS
typhus Dip-S-Ticks IBT for detecting IgM have potential for 
diagnosing acute infections. With a high specificity a positive 
result in either test is a reliable marker of scrub typhus or 
murine typhus but, in their current format, they have low sen-
sitivity to be clinically useful. Further development of these 
tests, perhaps with a lower antibody cut-off value, as expressed 
visually, may increase the sensitivity. 
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